Author:
Mullen K. D.,Szauter K. M.,Kaminsky K.,Tolentino P. D.,McCullough A. J.
Reference11 articles.
1. Mullen KD, Martin JV, Mendelson WB, Bassett ML, Jones EA. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? Lancet i 457–459,1988.
2. Baraldi M, Zeneroli ML, Ventura E, et al. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat reversal by benzodiazepine antagonist. Clin Sci 67:167–175,1984.
3. Bassett ML, Mullen KD, Skolnick P, Jones EA. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastro 93:1069–1077,1987.
4. Hamon M, Soubrie P. Searching for endogenous ligand(s) of central benzodiazepine receptors. Neurochem Int, 5:663–672,1983.
5. File S, Pellow S. Do the intrinsic actions of benzodiazepine receptor antagonists imply the existence of an endogenous ligand for benzodiazepine receptors? In: Advances in Biochemical Psychopharmacology: GABAergic Transmission and Anxiety. Raven Press, New York, 98–107,1986.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献